Biologically Active Small Molecules, 289499-45-2
1 - 2 of 2
Sort
View
Show
-
Canertinib Dihydrochloride
LKT LabsCanertinib is an irreversible inhibitor of EGFR (HER2/ErbB). This compound is currently in clinical trials as an anticancer chemotherapeutic, displaying activity against a variety of cancers. In a cellular model of melanoma, canertinib exhibits cytostatic activity, stopping cell growth in the G1…
-
Canertinib (hydrochloride)
Cayman ChemicalAn irreversible quinazoline-based HER family tyrosine kinase inhibitor with IC50 values of 0.8, 19, and 7 nM for blocking in vitro activity of EGFR, HER2, and HER4, respectively; inhibits the proliferation of various tumor cells.
Site Search by